HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
 Help
Order: Signal: Tickers:
Filters
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Maps Stats
Total: 200 #1 Type: candle | line | technical    Timeframe: daily | intraday    Auto Refresh: 3min | off
TickerPIXY [NASD]
CompanyShiftPixy, Inc.
CountryUSA
IndustryStaffing & Employment Services
Market Cap8.74MEPS (ttm)-133.90
P/E-EPS this Y83.70%
Forward P/E-EPS next Y-
PEG-EPS past 5Y22.10%
P/S0.23EPS next 5Y-
P/B0.05EPS Q/Q-47.20%
Dividend-Sales Q/Q1.10%
Insider Own40.50%Inst Own3.30%
Insider Trans0.00%Inst Trans-99.08%
Short Float0.05%Earnings-
Analyst Recom-Target Price-
Avg Volume73.08K52W Range11.06 - 203.00
Sep-08-22 10:07AMShiftPixy stock soars on record volume, after plan to spin off ShiftPixy Labs business MarketWatch
Sep-08-22 08:00AMShiftPixy Announces Plans to Spin-off ShiftPixy Labs and Dividend its Digital Securities to Shareholders Business Wire
Sep-07-22 08:00AMShiftPixy Announces Application for Dual Listing on Upstream Business Wire
Aug-31-22 12:44PMShiftPixy, Inc. Announces Reverse Stock Split Effective Date Business Wire
May-24-22 04:15PMShiftPixy, Inc. Announces Management Changes Business Wire
May-13-22 07:30AMShiftPixy, Inc. Announces Special Distribution of Shares of Industrial Human Capital, Inc. Business Wire
Mar-18-22 05:00PMShiftPixy, Inc. Announces Revised SPAC Sponsorship Business Wire
Feb-08-22 03:59PMShiftPixy Is Giving Itself Many Ways to Win by Diversifying Its Business InvestorPlace
Feb-01-22 07:00AMCEO Presenting on the Emerging Growth Conference on February 2 Register Now GlobeNewswire
Jan-24-22 02:16PMShort Squeeze Stocks: PIXY, MBOT and 3 Others Experts Think Are Ready to Pop InvestorPlace
TickerSHPH [NASD]
CompanyShuttle Pharmaceuticals Holdings, Inc.
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap483.51MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own63.42%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume7.11M52W Range11.77 - 126.26
Sep-06-22 09:00AMShuttle Pharmaceuticals Announces Closing of Initial Public Offering PR Newswire
Aug-31-22 01:20PMShuttle Pharmaceuticals Commences Trading on Nasdaq Under Ticker Symbol "SHPH" PR Newswire
Aug-30-22 04:40PMShuttle Pharmaceuticals Announces Pricing of Initial Public Offering PR Newswire
TickerNUTX [NASD]
CompanyNutex Health, Inc.
CountryUSA
IndustryHealth Information Services
Market Cap2.23BEPS (ttm)-0.14
P/E-EPS this Y68.20%
Forward P/E-EPS next Y-
PEG-EPS past 5Y42.20%
P/S15.01EPS next 5Y-
P/B3.91EPS Q/Q56.10%
Dividend-Sales Q/Q994.30%
Insider Own89.10%Inst Own1.10%
Insider Trans0.00%Inst Trans-
Short Float0.90%Earnings-
Analyst Recom-Target Price-
Avg Volume1.28M52W Range2.36 - 52.80
Aug-29-22 06:00AMNutex Health Named 2022 Innovation Award Honoree by The Houston Business Journal PR Newswire
Aug-22-22 06:02PMNUTEX HEALTH REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS PR Newswire
Aug-08-22 08:00AMTraders News Source Senior Editor Mark Roberts Interviews CEO of Nutex Health Tom Vo ACCESSWIRE
Jul-21-22 06:00AMNUTEX HEALTH HOSPITALS WIN MULTIPLE AWARDS PR Newswire
Jul-13-22 06:00AMNutex health provides update on growth strategy PR Newswire
Jul-05-22 07:46AMWhat Kind Of Investors Own Most Of Nutex Health, Inc. (NASDAQ:NUTX)? Simply Wall St.
Jun-27-22 06:00AMNUTEX HEALTH ANNOUNCES THAT IT HAS BEEN SELECTED TO JOIN BOTH THE RUSSELL 2000® AND RUSSELL 3000® INDEXES PR Newswire
Jun-10-22 06:00AMNUTEX HEALTH ANNOUNCES THE APPOINTMENT OF JON BATES AS ITS NEW CHIEF FINANCIAL OFFICER PR Newswire
May-23-22 05:00AMNUTEX HEALTH ANNOUNCES THAT ITS CEO HAS BEEN INVITED TO PARTICIPATE IN J.P. MORGAN'S 7TH ANNUAL FOUNDERS FORUM IN NEW YORK CITY PR Newswire
May-16-22 03:00AMNUTEX HEALTH ANNOUNCES TWO NEW FULLY FUNCTIONAL MICRO HOSPITALS PR Newswire
TickerRIBT [NASD]
CompanyRiceBran Technologies
CountryUSA
IndustryPackaged Foods
Market Cap14.63MEPS (ttm)-2.29
P/E-EPS this Y34.30%
Forward P/E-EPS next Y-
PEG-EPS past 5Y15.10%
P/S0.41EPS next 5Y40.00%
P/B0.95EPS Q/Q-18.30%
Dividend-Sales Q/Q34.20%
Insider Own6.80%Inst Own8.20%
Insider Trans-94.93%Inst Trans-63.75%
Short Float2.35%Earnings-
Analyst Recom3.00Target Price4.50
Avg Volume349.12K52W Range2.18 - 8.99
Aug-11-22 04:05PMRiceBran Technologies Reports Second Quarter 2022 Results ACCESSWIRE
Aug-01-22 08:00AMRiceBran Technologies to Host Second Quarter 2022 Financial Results Conference Call on August 11th, at 4:30 p.m. EST ACCESSWIRE
Jul-08-22 08:00AMRiceBran Technologies to Conduct Annual Shareholder Meeting on July 14, 2022 ACCESSWIRE
Jun-15-22 08:00AMRiceBran Technologies Pursues UFA Upcycled Certification, Reinforcing Commitment to Sustainable Manufacturing Practices and Positively Impacting the Environment ACCESSWIRE
Jun-01-22 08:00AMRiceBran Technologies Expands Mermentau, LA Facility to Meet Increasing Demand from the Rapidly Growing Companion Animal Market ACCESSWIRE
May-24-22 07:30AMRiceBran Technologies To Present at The LD Micro Invitational XII ACCESSWIRE
May-18-22 08:00AMRiceBran Technologies Expands MGI Grain to Meet Increasing Demand ACCESSWIRE
Apr-28-22 04:19PMRiceBran Technologies Reports First Quarter 2022 Results ACCESSWIRE
Apr-28-22 04:06PMRiceBran Technologies Names Experienced Food and Nutraceutical Executives to Board of Directors ACCESSWIRE
Apr-20-22 08:00AMRiceBran Technologies to Host First Quarter 2022 Financial Results Conference Call on April 28th, at 4:30 p.m. EST ACCESSWIRE
TickerINM [NASD]
CompanyInMed Pharmaceuticals Inc.
CountryCanada
IndustryBiotechnology
Market Cap124.54MEPS (ttm)-1.37
P/E-EPS this Y34.20%
Forward P/E-EPS next Y51.00%
PEG-EPS past 5Y-
P/S216.71EPS next 5Y-
P/B5.97EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own0.78%Inst Own9.05%
Insider Trans25.83%Inst Trans-
Short Float-Earnings-
Analyst Recom3.00Target Price3.40
Avg Volume35.45K52W Range5.82 - 59.25
Aug-23-22 05:00PMInMed Announces Share Consolidation to Meet Nasdaq Listing Criteria GlobeNewswire
Aug-09-22 07:30AMInMed Announces Changes to its Board of Directors GlobeNewswire
Jul-25-22 07:30AMInMed Announces Update on Phase 2 Clinical Trial Investigating INM-755 Cannabinol Cream for Epidermolysis Bullosa GlobeNewswire
Jul-18-22 07:30AMInMed Announces Appointment of Chief Operating Officer GlobeNewswire
Jul-12-22 11:33PMInMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance GlobeNewswire
Jun-14-22 07:30AMInMed Announces Publication of Peer-Reviewed Study Highlighting Potential Role of Rare Cannabinoids THCV, CBC and others on Skin Conditions GlobeNewswire
Jun-09-22 07:30AMInMed Launches THCV, Expanding its Portfolio of Rare Cannabinoids for the Health and Wellness Sector GlobeNewswire
Jun-06-22 06:49PMInMed Pharmaceuticals Announces Closing of $5 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules GlobeNewswire
Jun-02-22 08:00AMInMed Pharmaceuticals Announces $5 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules GlobeNewswire
May-13-22 08:45AMInMed Pharmaceuticals Inc. (INM) Reports Q3 Loss, Misses Revenue Estimates Zacks
TickerTC [NASD]
CompanyTuanChe Limited
CountryChina
IndustryInternet Content & Information
Market Cap41.99MEPS (ttm)-0.76
P/E-EPS this Y38.00%
Forward P/E-EPS next Y-
PEG-EPS past 5Y23.20%
P/S0.81EPS next 5Y-
P/B1.64EPS Q/Q-62.30%
Dividend-Sales Q/Q-49.90%
Insider Own34.92%Inst Own12.60%
Insider Trans0.00%Inst Trans0.40%
Short Float0.12%Earnings-
Analyst Recom3.00Target Price-
Avg Volume15.72K52W Range1.42 - 3.95
Apr-29-22 05:45PMTuanChe Files Its Annual Report on Form 20-F PR Newswire
Apr-07-22 07:30AMTing Internet to build the first city-wide fiber network in Aurora, Colorado PR Newswire
Apr-04-22 06:00AMTuanChe Announces Unaudited Fourth Quarter and Full Year 2021 Financial Results PR Newswire
Jan-21-22 05:00AMTuanChe Outlines Preliminary Plan for Its EV Business PR Newswire
Jan-13-22 02:00AMTuanChe Announces Unaudited Third Quarter 2021 Financial Results PR Newswire
Jan-10-22 09:29AMTuanChe Expands into EV Market, Differentiating Itself from Competitors with A Strong Sales Network PR Newswire
Jan-07-22 06:00AMTuanChe Limited to Report Third Quarter 2021 Financial Results on January 13, 2022 PR Newswire
Jan-05-22 06:00AMTuanChe Announces Plan to Strategically Expand into Electric Vehicle Manufacturing Sector PR Newswire
Nov-17-21 06:00AMTuanChe Limited Announces Results of Annual General Meeting of Shareholders PR Newswire
Nov-12-21 08:30AMTuanChe Announces Receipt of Withdrawal of Going Private Proposal PR Newswire
TickerAVAV [NASD]
CompanyAeroVironment, Inc.
CountryUSA
IndustryAerospace & Defense
Market Cap2.23BEPS (ttm)-0.17
P/E-EPS this Y-117.70%
Forward P/E41.18EPS next Y41.18%
PEG-EPS past 5Y-17.30%
P/S5.01EPS next 5Y18.20%
P/B3.61EPS Q/Q-33.60%
Dividend-Sales Q/Q-2.50%
Insider Own1.00%Inst Own87.70%
Insider Trans-4.30%Inst Trans1.32%
Short Float3.72%EarningsSep 07/a
Analyst Recom2.20Target Price96.33
Avg Volume244.73K52W Range52.03 - 114.11
Sep-08-22 08:06AMAeroVironment (AVAV) Reports Loss in Q1, Sales Improve Y/Y Zacks
Sep-07-22 11:30PMAeroVironment (AVAV) Q1 2023 Earnings Call Transcript Motley Fool
Sep-07-22 05:35PMAeroVironment (AVAV) Reports Q1 Loss, Tops Revenue Estimates Zacks
Sep-07-22 04:30PMEdited Transcript of AVAV.OQ earnings conference call or presentation 7-Sep-22 8:30pm GMT Thomson Reuters StreetEvents
Sep-07-22 04:10PMAeroVironment Announces Fiscal 2023 First Quarter Results Business Wire
Aug-30-22 09:10AMAeroVironments New Mantis i23 D Multi-Sensor Imaging Payload Delivers Superior Daytime Surveillance Performance Business Wire
Aug-26-22 04:19PM7 Growth Stocks With Huge Catalysts Ahead InvestorPlace
Aug-24-22 01:10PMAeroVironment, Inc. Schedules First Quarter Fiscal Year 2023 Earnings Release and Conference Call Business Wire
Aug-23-22 09:10AMAeroVironment Releases Inaugural Corporate Social Responsibility Report Business Wire
Aug-22-22 02:22PMAeroVironment Price Target Bumped Up By 15% At RBC Capital Benzinga
TickerLFST [NASD]
CompanyLifeStance Health Group, Inc.
CountryUSA
IndustryMedical Care Facilities
Market Cap2.78BEPS (ttm)-1.03
P/E-EPS this Y-26.00%
Forward P/E-EPS next Y72.50%
PEG-EPS past 5Y-
P/S3.58EPS next 5Y-
P/B1.76EPS Q/Q13.00%
Dividend-Sales Q/Q30.50%
Insider Own13.50%Inst Own83.90%
Insider Trans-1.81%Inst Trans1.26%
Short Float2.69%EarningsAug 09/a
Analyst Recom2.30Target Price8.80
Avg Volume665.68K52W Range4.77 - 16.50
Sep-08-22 09:00AMLifeStance Health Appoints Ken Burdick as CEO and Chairman; Founding CEO and Chairman Michael Lester Retires PR Newswire
Aug-30-22 04:10PMLifeStance to Participate in the Morgan Stanley Global Healthcare Conference GlobeNewswire
Aug-15-22 08:34AMLifeStance Health Group, Inc. (NASDAQ:LFST) Shares Could Be 37% Below Their Intrinsic Value Estimate Simply Wall St.
Aug-10-22 12:30AMLifeStance Health Group, Inc. (LFST) Q2 2022 Earnings Call Transcript Motley Fool
Aug-09-22 07:45PMLifeStance Health Group (LFST) Reports Q2 Loss, Lags Revenue Estimates Zacks
Aug-09-22 04:10PMLifeStance Reports Second Quarter 2022 Results GlobeNewswire
Jul-19-22 05:00PMLifeStance to Host Second Quarter 2022 Earnings Conference Call on August 9, 2022 GlobeNewswire
Jul-08-22 08:13AMLifeStance Health (LFST) Soars 6.2%: Is Further Upside Left in the Stock? Zacks
Jul-07-22 09:00AMGwen Booth Named Executive Director of LifeStance Health Foundation PR Newswire
Jul-04-22 02:53PMInvestors are selling off LifeStance Health Group (NASDAQ:LFST), lack of profits no doubt contribute to shareholders one-year loss Simply Wall St.
TickerBIAF [NASD]
CompanybioAffinity Technologies, Inc.
CountryUSA
IndustryDiagnostics & Research
Market Cap8.74MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S6692.19EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume10.56M52W Range5.08 - 15.55
Sep-06-22 01:54PMWallachBeth Capital Announces Closing Of bioAffinity Technologies, Inc. $7.8 Million Initial Public Offering PR Newswire
Sep-06-22 11:28AMbioAffinity Technologies, Inc. Announces Closing of $7.8 Million Initial Public Offering Business Wire
Sep-01-22 12:32PMWallachBeth Capital Announce Pricing Of bioAffinity Technologies IPO At $6.125 Per Unit PR Newswire
Sep-01-22 08:15AMbioAffinity Technologies Announces Pricing of IPO Business Wire
TickerGRFX [AMEX]
CompanyGraphex Group Limited
CountryHong Kong
IndustryOther Industrial Metals & Mining
Market Cap63.41MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.17EPS next 5Y-
P/B0.15EPS Q/Q-
Dividend-Sales Q/Q-10.70%
Insider Own-Inst Own0.01%
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume2.00M52W Range1.50 - 4.66
Aug-31-22 07:01AMGraphex Group Announces Interim Financial Highlights and Global Expansion Progress GlobeNewswire
Aug-26-22 04:15PMGraphex Group Limited Announces Full Exercise of Over-Allotment Option in Underwritten Public Offering GlobeNewswire
Aug-22-22 09:29AMGraphex Technologies Highlights U.S. Expansion Progress and Outlines Business Strategy GlobeNewswire
Aug-19-22 04:05PMGraphex Group Limited Announces Closing of Upsized $11.7 Million Public Offering and NYSE American Listing GlobeNewswire
Aug-16-22 07:08PMGraphex Group Limited Announces Pricing of Upsized $11.7 Million Public Offering and NYSE American Listing GlobeNewswire
123456 ... 10 ... 20next
affiliate • advertise • contact • privacy • help
Do Not Sell My Data • Privacy Settings
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2022 FINVIZ.com. All Rights Reserved.